Presentation Information
[28-14-am06]Corporate Policy Changes Following Q&A on Sales Guidelines for Ethical Drugs
○Katsunori Yamaura1, Ririka Mima1, Shingo Kondo1, Hiroki Iwata1, Noriko Kobayashi1, Shinichi Watanabe2 (1. Keio Univ. Faculty Pharm., 2. Teikyo Heisei Univ. Faculty Pharm.)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.